Literature DB >> 22939029

Compensatory cognitive training for psychosis: effects in a randomized controlled trial.

Elizabeth W Twamley1, Lea Vella, Cynthia Z Burton, Robert K Heaton, Dilip V Jeste.   

Abstract

OBJECTIVE: Treatments for the cognitive impairments of schizophrenia are urgently needed. We developed and tested a 12-week, group-based, manualized, compensatory cognitive training intervention targeting prospective memory, attention, learning/memory, and executive functioning. The intervention focused on compensatory strategies, such as calendar use, self-talk, note taking, and a 6-step problem-solving method, and did not require computers.
METHOD: In a randomized controlled trial, 69 outpatients with DSM-IV primary psychotic disorders were assigned to receive standard pharmacotherapy alone or compensatory cognitive training + standard pharmacotherapy for 12 weeks. Assessments of neuropsychological performance and functional capacity (primary outcomes) and psychiatric symptom severity, quality of life, social skills performance, cognitive insight, and self-reported everyday functioning (secondary outcomes) were administered at baseline, posttreatment, and 3-month follow-up. Data were collected between September 2003 and August 2009.
RESULTS: Hierarchical linear modeling analyses demonstrated significant compensatory cognitive training-associated effects on attention at follow-up (P = .049), verbal memory at posttreatment and follow-up (P values ≤ .039), and functional capacity (University of California, San Diego Performance-based Skills Assessment) at follow-up (P = .004). The compensatory cognitive training group also differentially improved in negative symptom severity at posttreatment and follow-up (P values ≤ .025) and subjective quality of life at follow-up (P = .002).
CONCLUSIONS: Compensatory cognitive training, a low-tech, brief intervention, has the potential to improve not only cognitive performance but also functional skills, negative symptoms, and self-rated quality of life in people with psychosis. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01521026. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22939029      PMCID: PMC3593661          DOI: 10.4088/JCP.12m07686

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  40 in total

1.  The independent living skills survey: a comprehensive measure of the community functioning of severely and persistently mentally ill individuals.

Authors:  C J Wallace; R P Liberman; R Tauber; J Wallace
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

2.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

Review 3.  Real-world cognitive--and metacognitive--dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff".

Authors:  Danny Koren; Larry J Seidman; Morris Goldsmith; Phillip D Harvey
Journal:  Schizophr Bull       Date:  2006-01-05       Impact factor: 9.306

4.  Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial.

Authors:  Shaun M Eack; Deborah P Greenwald; Susan S Hogarty; Susan J Cooley; Ann Louise DiBarry; Debra M Montrose; Matcheri S Keshavan
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

5.  Compensatory cognitive training for psychosis: who benefits? Who stays in treatment?

Authors:  Elizabeth W Twamley; Cynthia Z Burton; Lea Vella
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

6.  Social skills performance assessment among older patients with schizophrenia.

Authors:  T L Patterson; S Moscona; C L McKibbin; K Davidson; D V Jeste
Journal:  Schizophr Res       Date:  2001-03-30       Impact factor: 4.939

7.  Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises.

Authors:  B E Wexler; M Anderson; R K Fulbright; J C Gore
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

8.  Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial.

Authors:  Susan R McGurk; Kim T Mueser; Karin Feldman; Rosemarie Wolfe; Alysia Pascaris
Journal:  Am J Psychiatry       Date:  2007-03       Impact factor: 18.112

9.  Insight into neurocognitive dysfunction in schizophrenia.

Authors:  Alice Medalia; Julie Thysen
Journal:  Schizophr Bull       Date:  2008-01-16       Impact factor: 9.306

Review 10.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

View more
  48 in total

1.  A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder.

Authors:  J Cobb Scott; Georg E Matt; Kristen M Wrocklage; Cassandra Crnich; Jessica Jordan; Steven M Southwick; John H Krystal; Brian C Schweinsburg
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Nicotine improves probabilistic reward learning in wildtype but not alpha7 nAChR null mutants, yet alpha7 nAChR agonists do not improve probabilistic learning.

Authors:  Morgane Milienne-Petiot; Kerin K Higa; Andrea Grim; Debbie Deben; Lucianne Groenink; Elizabeth W Twamley; Mark A Geyer; Jared W Young
Journal:  Eur Neuropsychopharmacol       Date:  2018-09-11       Impact factor: 4.600

Review 3.  Cognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacy.

Authors:  Jimmy Choi; Elizabeth W Twamley
Journal:  Neuropsychol Rev       Date:  2013-02-12       Impact factor: 7.444

Review 4.  Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action.

Authors:  Erica Weber; Kaitlin Blackstone; Steven Paul Woods
Journal:  Neuropsychol Rev       Date:  2013-02-16       Impact factor: 7.444

5.  Compensatory cognitive training for people with severe mental illnesses in supported employment: A randomized controlled trial.

Authors:  Elizabeth W Twamley; Kelsey R Thomas; Cynthia Z Burton; Lea Vella; Dilip V Jeste; Robert K Heaton; Susan R McGurk
Journal:  Schizophr Res       Date:  2017-08-18       Impact factor: 4.939

6.  Age and Improved Attention Predict Work Attainment in Combined Compensatory Cognitive Training and Supported Employment for People With Severe Mental Illness.

Authors:  Olga Puig; Kelsey R Thomas; Elizabeth W Twamley
Journal:  J Nerv Ment Dis       Date:  2016-11       Impact factor: 2.254

7.  Assessment of 3-dimensional wisdom in schizophrenia: Associations with neuropsychological functions and physical and mental health.

Authors:  Ryan Van Patten; Ellen E Lee; Rebecca Daly; Elizabeth Twamley; Xin M Tu; Dilip V Jeste
Journal:  Schizophr Res       Date:  2019-02-14       Impact factor: 4.939

8.  Novel treatment for geriatric hoarding disorder: an open trial of cognitive rehabilitation paired with behavior therapy.

Authors:  Catherine R Ayers; Sanjaya Saxena; Emmanuel Espejo; Elizabeth W Twamley; Eric Granholm; Julie Loebach Wetherell
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-03       Impact factor: 4.105

9.  Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Authors:  Veronica B Perez; Neal R Swerdlow; David L Braff; Risto Näätänen; Gregory A Light
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

10.  Pupillometer-based neurofeedback cognitive training to improve processing speed and social functioning in individuals at clinical high risk for psychosis.

Authors:  Jimmy Choi; Cheryl M Corcoran; Joanna M Fiszdon; Michael Stevens; Daniel C Javitt; Melissa Deasy; Lawrence C Haber; Michael J Dewberry; Godfrey D Pearlson
Journal:  Psychiatr Rehabil J       Date:  2016-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.